Posts

VRDN: Neutral Technical Setup at Key Support Offers Measured Swing Opportunity

VRDN — Playbook & Thesis 2026-06-21 • Personal Trading Playbook VRDN — Playbook & Thesis VRDN — Expanded Analysis & Plan Risk Disclaimer: This is not financial advice. Trading involves substantial risk of loss. Only risk capital you can afford to lose. Executive Summary Published: June 21, 2026 | Technical Analysis & Trade Plan PDUFA Catalyst The primary near-term catalyst is the FDA's target action date of June 30, 2026, for veligrotug's BLA in thyroid eye disease (TED) under Priority Review. The application was accepted in late 2025 and granted Breakthrough Therapy Designation earlier. No additional PDUFA extensions or delays have been announced as of June 21, 2026. Secondary readouts include topline Phase 3 data for elegrobart (VRDN-003) in active TED (REVEAL-1) expected in Q1 2026 and chronic TED (REVEAL-2) in Q2 2026, with potential BLA submission for the subcutaneous asset by year-en...
Post a Comment
Read more

AMD Momentum Breakout: Moderate-Conviction Swing Setup

AMD: Momentum Breakout on Strong Volume — Moderate Conviction Swing Setup 2026-06-20 • Personal Playbook Blog • Swing Trade Setup AMD: Momentum Breakout on Strong Volume — Moderate Conviction Swing Setup AMD Risk Disclaimer: This is NOT financial advice. Trading involves substantial risk of loss, including possible loss of principal. Past performance is not indicative of future results. All analysis is for educational and personal use only. Do your own research and consult a licensed financial advisor before trading. Executive Summary Setup Type Swing Long Momentum breakout on strong volume Conviction Score 54 / 100 Moderate — mixed signals Position Size 1–2% Portfolio Starter / probe size only Time Horizon 2–4 Weeks Hold 10–28 days typical Risk / Reward 1 : 1.5 Blended (Peak 1:2.3) ...
Post a Comment
Read more

PIII: Neutral RSI Pullback Creates Patient Swing Entry at Key Support

PIII: Neutral RSI Pullback Creates Cautious Swing Opportunity After Recent Spike 2026-06-20 • Personal Playbook Blog • Swing Trade Setup PIII: Neutral RSI Pullback Creates Cautious Swing Opportunity After Recent Spike PIII Risk Disclaimer: This is NOT financial advice. Trading involves substantial risk of loss, including possible loss of principal. Past performance is not indicative of future results. All analysis is for educational and personal use only. Do your own research and consult a licensed financial advisor before trading. Executive Summary Setup Type Swing Long Neutral RSI pullback after spike Conviction Score 65 / 100 Moderate — solid R:R, needs reload Position Size 2–3% Portfolio Half size (scale in at entry) Time Horizon 2–4 Weeks Typical hold: 10–28 days Risk / Reward 1 : 2.4 Blende...
Post a Comment
Read more

FRMI’s AI Power Gambit: My Full Trading Playbook

FRMI — Expanded Playbook & Thesis | June 19, 2026 2026-06-19 • Personal Playbook Blog • Swing / Catalyst Trade FRMI — Expanded Playbook & Thesis Fermi Inc. (NASDAQ: FRMI) Project Matador AI Power Infrastructure 📈 Open on TradingView Yahoo Finance ⚠️ RISK DISCLAIMER: This is NOT financial advice . Trading involves substantial risk of loss and is not suitable for all investors. Past performance is not indicative of future results. The levels below were generated for educational / personal planning purposes. Always do your own due diligence, manage risk aggressively, and never risk capital you cannot afford to lose. ...
Post a Comment
Read more

AXTI Deep Look

2026-06-19 • Personal Playbook Blog • Updated AXTI — Weak Swing Playbook AXT, Inc. (NASDAQ: AXTI) ⚠️ LOW CONVICTION • 28/100 ⚠️ Risk Disclaimer: This is not financial advice . Trading involves substantial risk of loss, including possible loss of principal. AXTI is an extremely volatile, high-beta name with parabolic moves in both directions. Past performance (including the massive rally from sub-$2 to $143) is not indicative of future results. Do your own research. Position sizing must be tiny. The author may or may not hold a position. Executive Summary — Why This Remains Weak Current Price (as of June 18/19 close): ~$84.57 (−8.2% today) . 52-week range: $1.80 – $143.16. Market cap ≈ $5.53B. The original assessment of low conviction (weak swing) still stands — and is arguably more cautious now. The stock has extended further fr...
Post a Comment
Read more

TE Moderate Chance Swing

TE Stock: Volume-Support Swing Setup Emerges Amid AI-Driven Solar Tailwinds • June 19, 2026 June 19, 2026 • Personal Playbook Blog • Updated with latest price action TE Stock: Volume-Support Swing Setup Emerges Amid AI-Driven Solar Tailwinds NYSE: TE  •  T1 Energy Inc. ⚠️ Risk Disclaimer: This is not financial advice . Trading involves substantial risk of loss and is not suitable for all investors. Past performance is not indicative of future results. Always do your own due diligence and consider your risk tolerance, time horizon, and financial situation. Position sizing and risk management are critical. Quick context: T1 Energy (TE) is a U.S.-focused solar module and cell manufacturer building domestic supply chain capacity. The stock has attracted attention due to surging power demand from AI data centers and policy support for American-made clean energy. This post docu...
Post a Comment
Read more

ATXI Playbook

ATXI — Weak Swing Playbook (Expanded) • June 2026 WEAK CONVICTION • HIGH RISK • LOW LIQUIDITY ATXI Avenue Therapeutics, Inc. CURRENT PRICE (OTC) $0.27 −15.6% Last close • Low volume session Verdict: WATCHLIST ONLY — 0.25–0.5% MAX ALLOCATION Score: 32/100 • Updated post recent weakness Probability-Weighted View Blended Expected Return: +18% to +32% Probability-weighted Risk/Reward ≈ 1 : 2.1 (only with tiny size) ...
Post a Comment
Read more